6-158573511-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000367090.4(TMEM181):c.223G>A(p.Val75Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,453,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V75F) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000367090.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM181 | NM_001376852.1 | c.100G>A | p.Val34Ile | missense_variant | 2/17 | ENST00000684151.1 | NP_001363781.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM181 | ENST00000684151.1 | c.100G>A | p.Val34Ile | missense_variant | 2/17 | NM_001376852.1 | ENSP00000507085.1 | |||
TMEM181 | ENST00000367090.4 | c.223G>A | p.Val75Ile | missense_variant | 2/17 | 1 | ENSP00000356057.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000432 AC: 1AN: 231320Hom.: 0 AF XY: 0.00000799 AC XY: 1AN XY: 125204
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1453108Hom.: 0 Cov.: 31 AF XY: 0.0000222 AC XY: 16AN XY: 721978
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.511G>A (p.V171I) alteration is located in exon 2 (coding exon 2) of the TMEM181 gene. This alteration results from a G to A substitution at nucleotide position 511, causing the valine (V) at amino acid position 171 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at